Premium
Monitoring and treatment of anti‐D in pregnancy
Author(s) -
Bettelheim D.,
Panzer S.,
Reesink H. W.,
Csapo B.,
Pessoa C.,
Guerra F.,
Wendel S.,
Calda P.,
Sprogøe U.,
Dziegiel M.,
AitokallioTallberg A.,
Koskinen S.,
Kuosmanen M.,
Legler T. J.,
Stein W.,
Villa S.,
Villa M. A.,
Trespidi L.,
Acaia B.,
Vandenbussche F. P. H. A.,
Brand A.,
De Haas M.,
Kanhai H. H. H.,
Gounder D.,
Flanagan P.,
Donegan R.,
Parry E.,
Sefonte C.,
Skulstad S. M.,
Hervig T.,
Flesland Ø.,
Żupańska B.,
Uhrynowska M.,
Lapaire O.,
Zhong X. Y.,
Holzgreve W.
Publication year - 2010
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/j.1423-0410.2010.01322.x
Subject(s) - pregnancy , medicine , obstetrics , gynecology , intensive care medicine , biology , genetics
Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts in public health expenses have increased the incidence of anti-D immunization in many "developed" countries. Therefore, this forum focuses on prenatal monitoring standards and treatment strategies in pregnancies with anti-D alloimmunization. The following questions were addressed, and a response was obtained from 12 centres, mainly from Europe.